Aya Emam- Master of Pharmaceutical sciences
- Assistant lecturer at Zagazig University
Aya Emam
- Master of Pharmaceutical sciences
- Assistant lecturer at Zagazig University
PhD student, University of Manchester, UK.
About
4
Publications
175
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
12
Citations
Introduction
Skills and Expertise
Current institution
Additional affiliations
September 2021 - September 2025
Publications
Publications (4)
Citation: Belgath, A.A.; Emam, A.M.; Taujanskas, J.; Bryce, R.A.; Freeman, S.; Stratford, I.J. Discovery of Potent Benzothiazole Inhibitors of Oxidoreductase NQO2, a Target for Inflammation and Cancer. Int. J. Mol. Sci. 2024, 25, 12025. https://doi. Abstract: Inhibitors of NQO2 (NRH: quinone oxidoreductase) have potential application in several are...
Antibacterial agents structurally based on quinazolin-4-one pharmacophore, have been designed and synthesized. Where the targeted compounds 5a, c and 6a-c were in vitro screened against three gram positive and three gram negative bacteria strains compared to ciprofloxacin as reference drug. Most of compounds had moderate antibacterial activity whil...
Globally, lung cancer and tuberculosis are considered to be very serious and complex diseases. Evidence suggests that chronic infection with tuberculosis (TB) can often lead to lung tumors; therefore, developing drugs that target both diseases is of great clinical significance. In our study, we designed and synthesized a suite of 14 new quinazolino...
The discovery of more selective and safer voltage-gated potassium channel blockers is an extremely demanding approach. Designing selective Kv1.5 inhibitors is very challenging as only limited data is available on this target due to a lacking crystal structure for this ion channel receptor. Herein, we synthesized a series of 21 novel quinazolinone d...
